Publications by authors named "Elizabeth A Guancial"

23Publications

Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor ╬▓/IL-1/c-MET signals.

Cancer Lett 2018 08 22;430:215-223. Epub 2018 Apr 22.

Departments of Urology and Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA. Electronic address:

View Article and Find Full Text PDF
August 2018

Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer.

Clin Genitourin Cancer 2017 02 10;15(1):e95-e97. Epub 2016 Aug 10.

Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI.

View Article and Find Full Text PDF
February 2017

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

PLoS One 2016 17;11(5):e0155503. Epub 2016 May 17.

Department of Medicine/James P. Wilmot Cancer Institute, University of Rochester, Rochester, New York, United States of America.

View Article and Find Full Text PDF
July 2017

Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma.

Clin Genitourin Cancer 2016 08 24;14(4):352-9. Epub 2015 Dec 24.

Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article and Find Full Text PDF
August 2016

Bladder cancer in the elderly patient: challenges and solutions.

Clin Interv Aging 2015 10;10:939-49. Epub 2015 Jun 10.

Division of Hematology/Oncology, Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center School of Medicine and Dentistry, Rochester, NY, USA.

View Article and Find Full Text PDF
February 2016

The role of genomics in the management of advanced bladder cancer.

Curr Treat Options Oncol 2015 Jan;16(1):319

Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center School of Medicine and Dentistry, 601 Elmwood Ave, Box 704, Rochester, NY, 14642, USA,

View Article and Find Full Text PDF
January 2015

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Clin Cancer Res 2014 Apr 31;20(7):1873-83. Epub 2014 Jan 31.

Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain.

View Article and Find Full Text PDF
April 2014

The evolving understanding of microRNA in bladder cancer.

Urol Oncol 2014 Jan 2;32(1):41.e31-40. Epub 2013 Aug 2.

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.

View Article and Find Full Text PDF
January 2014

Case report: responses to cabazitaxel in metastatic castration-resistant prostate cancer after extensive docetaxel treatment.

Clin Genitourin Cancer 2011 Dec 3;9(2):130-2. Epub 2011 Aug 3.

Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA.

View Article and Find Full Text PDF
December 2011

Update in Urothelial Carcinoma: Novel Agents and Targeted Therapy.

Am Soc Clin Oncol Educ Book 2011 ;2011:171-176

Dana Farber Cancer Institute, 450 Brookline Avenue, Dana 1232, Boston, MA 02115, 617-632-4524 (telephone), 617-632-2165 (fax),

View Article and Find Full Text PDF
January 2011

Personalized therapy for urothelial cancer: review of the clinical evidence.

Clin Investig (Lond) 2011 Apr;1(4):546-555

Clinical Fellow in Hematology and Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Smith 353, Boston, MA 02115, 617-632-3779 (telephone), 617-632-5822 (fax),

View Article and Find Full Text PDF
April 2011